Organ On A Chip MarketSize and Trends

Organ-on-a-chip Market Overview

Organ on a chip is gaining prominence on the backdrop of regulatory measures on animal testing and growing complexity in therapeutic applications. Various players are trying to capitalize on lucrative growth opportunities in the organ-on-a-chip devices market. It is a unique cell culture process, wherein biomimetic microsystem is used as a platform.

These devices are built on silicone, which can be used to grow internal organs. This finds application in organ transplantation and also therapeutics. Harvard’s Wyss Institute is engaged in lung-on-chip production, commercialization of which would help in exponential growth of the organ on a chip market. Moreover, partnerships of biotech and pharmaceutical companies with universities is expected to scale up the commercialization process in the near future. This billion dollar industry is expected to create significant market opportunities for players. Some companies such as Mimetas are currently engaged in development of kidney-on-a-chip. This technology is gaining traction as this unique technology greatly reduces the amount of testing carried out on animals, while providing highly accurate results.

Funding and government initiatives are projected to further boost market growth in the near future. Though the market is expected to create substantial opportunities, high cost and early stage in R&D are some of the factors leading to slow growth of the market. Market is expected to witness rampant commercialization post-2020.